Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/10/004098
CTRI/2013/10/004098
Active, not recruiting
Phase 2

A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of cerebral palsy in subjects below 15 years. - BMCP2

Arvind Bagul0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Cerebral Palsy below 15 years.

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Cerebral Palsy below 15 years.
Sponsor
Arvind Bagul
Enrollment
100
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Arvind Bagul

Eligibility Criteria

Inclusion Criteria

  • •1\. Subjects aged above 3 years and below 15 years with a diagnosis of Cerebral Palsy.
  • •2\. Regional nerve damage as shown by Magnetic Resonance Imaging (MRI)
  • •3\. Able to comprehend and give informed consent for the study and willing to come to the hospital for follow up visits as per the protocol requirements (patient or his legal guardian).

Exclusion Criteria

  • •1\. History of meningitis, meningoencephalitis, epilepsy or life ?threatening allergic or immune\-mediated reaction
  • •2\. Hemodynamically unstable patients
  • •3\. History of or concurrent autoimmune disease or an acute episode of Guillain\-barre syndrome
  • •4\. Peripheral muscular dystrophy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of cerebral palsy in subjects above 15 years.Health Condition 1: null- Cerebral Palsy above 15 years
CTRI/2011/091/000159Chaitanya Stem Cell Center100
Active, not recruiting
Phase 2
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of stroke.
CTRI/2013/10/004105Arivind Bagul100
Active, not recruiting
Phase 2
A clinical trial to study the safety and efficacy of Bone marrow derived Autologous cells for the treatment of Chronic Paraplegia
CTRI/2013/10/004109Arvind Bagul100
Active, not recruiting
Phase 2
A clinical trial to study the safety and efficacy of Bone marrow derived autologous cells for the treatment of Acute ParaplegiaHealth Condition 1: null- Acute paraplegia
CTRI/2013/10/004099Chaitanya Vaidyakiya seva sanstha100
Terminated
Not Applicable
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusio
KCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20